Hong Kong (HSI) Tillväxt Aktier Pharmaceuticals & Biotech

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPPDATERAD May 20, 2026

Upptäck Hong Kong Pharmaceuticals & Biotech Tillväxtaktier som finns på HSI. Sorterade efter prognostiserad tillväxt har dessa Pharmaceuticals & Biotech Stocks högre vinst- eller försäljningstillväxt än förväntat jämfört med andra företag.

126 Företag

Företag	Senaste pris	7D Återkomst	1 års avkastning	Marknadsvärde	Analytikernas mål	Värdering	Tillväxt	Avkastning på aktier
3696	HK$45.84	-21.3%	n/a	HK$27.6b	HK$77.32	59.6	130.3%	n/a
570	HK$1.61	-1.8%	-25.1%	HK$8.2b	HK$1.86	0.3	113.8%	0%
9606	HK$224.40	-3.8%	8.8%	HK$20.4b	HK$435.33	9.5	101.0%	n/a
2487	HK$4.12	-5.3%	-50.4%	HK$1.5b	HK$11.28	3.9	99.3%	n/a
1548	HK$12.81	-11.9%	8.9%	HK$28.6b	HK$17.67	3.7	97.9%	0%
2591	HK$12.10	-11.4%	n/a	HK$6.2b	HK$31.59	36.5	95.4%	n/a
1477	HK$6.20	-10.4%	-19.5%	HK$5.0b	HK$9.51	5.5	94.6%	n/a
2616	HK$7.87	-3.4%	111.6%	HK$12.3b	HK$14.20	40.5	83.5%	n/a
2595	HK$35.40	-2.0%	n/a	HK$13.5b	HK$59.23	87.4	83.0%	n/a
1952	HK$31.86	1.0%	-26.4%	HK$11.1b	HK$49.65	5.7	82.7%	n/a
2171	HK$17.51	-20.1%	-22.9%	HK$9.5b	HK$21.22	65.1	82.1%	n/a
2480	HK$19.50	-1.6%	-5.3%	HK$3.9b	HK$31.00	5.1	77.1%	n/a
2162	HK$63.55	-7.2%	56.1%	HK$18.1b	HK$92.76	22.7	77.0%	n/a
2561	HK$24.40	3.8%	-48.1%	HK$2.7b	HK$51.05	16985.2	71.5%	n/a
1877	HK$23.86	-2.5%	40.5%	HK$40.0b	HK$29.74	7.8	69.1%	n/a
2228	HK$7.99	-6.4%	66.8%	HK$34.0b	HK$11.60	241.3	62.4%	n/a
9926	HK$120.00	-3.1%	39.5%	HK$105.9b	HK$172.91	31.4	60.6%	n/a
2629	HK$12.41	0%	n/a	HK$3.7b	HK$100.01	22.1	57.9%	n/a
6185	HK$27.58	-1.1%	-16.8%	HK$12.1b	HK$48.52	5.3	57.2%	0%
9887	HK$62.10	-9.3%	n/a	HK$12.0b	HK$94.61	60.5	55.1%	n/a
2565	HK$12.74	-7.2%	n/a	HK$6.0b	HK$101.80	9.6	49.9%	n/a
460	HK$1.03	-10.4%	13.2%	HK$9.8b	HK$2.00	45.0	49.2%	2.1%
6990	HK$453.60	4.3%	38.7%	HK$101.9b	HK$533.85	44.6	44.0%	n/a
2315	HK$51.00	-1.6%	247.9%	HK$45.7b	n/a	68.1	40.0%	n/a

Page 1 of 6